Trials / Conditions / Anthracycline-induced Cardiac Toxicity
Anthracycline-induced Cardiac Toxicity
3 registered clinical trials studyying Anthracycline-induced Cardiac Toxicity — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients NCT07254221 | Shiraz University of Medical Sciences | Phase 4 |
| Recruiting | Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Pa NCT07245069 | University Medical Centre Ljubljana | Phase 2 |
| Recruiting | REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs NCT05223413 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | N/A |